Contact Us
Zentraxa, Ltd.
Unit DX
St. Phillips Central, Albert Road
Bristol
BS2 0XJ
United Kingdom
info@zentraxa.com
Follow us:
Twitter: @Zentraxa_Ltd
Follow Us
The challenges and opportunities of protein and peptide commercialisation - @KTNUK's Dana Heldt explores '#directedevolution' and profiles some UK companies working in this space.
@labgeni_us @Zentraxa_Ltd @KTN_SynBioSIG @Biocats #synbio #biobased
KTN | The challenges and opportunities of protein and peptide commercialisation
KTN's Knowledge Transfer Manager for Synthetic Biology, Dana Heldt explores 'directed evolution' and profiles some UK companies working in this space.
bit.ly
Sunrise run through Glen Canyon Park to shake the jetlag and now ready for #SynBioBeta2018 Come say hello at the @SynbiCITE stand if you want the know about @BrisSynBio's world-class #synbio #research and supported companies @Zentraxa_Ltd @CYTOSEEK Imophoron and @VitamicaAMR
#PRESS Novo Nordisk acquires Ziylo Ltd to accelerate its development of glucose responsive insulins
We are very proud to announce that @ziylo has been acquired by @novonordisk in a deal that could exceed USD$800m. This could lead to the development of a ground-breaking treatment for #diabetes patients, demonstrating the global impact of #Bristol science. https://t.co/mYpslKus26
The Unit DX June newsletter is now online. Featuring @Corr_Associates @Zentraxa_Ltd @kets_quantum @spinup_science @H_Destecroix @RoySocChem @bristoldc @insiderswest @davidclensy #SBT Read it and subscribe - https://t.co/1OwktYenCy
